STUDY TO EVALUATE THE EFFICACY, SAFETY AND PHARMACOKINETICS OF THREE-TIMES WEEKLY DOSING OF GSK1278863 IN HEMODIALYSIS-DEPENDENT SUBJECTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE WHO ARE SWITCHED FROM A STABLE DOSE OF AN ERYTHROPOIESIS-STIMULATING AGENT: